Kling Biotherapeutics Appoints Michael Koslowski, M.D. As Ch

/PRNewswire/ -- Kling Biotherapeutics, B.V., a clinical-stage company pioneering the discovery and development of novel antibody-based therapeutics, today...

Related Keywords

Germany , Saarland , Amsterdam , Noord Holland , Netherlands , German , Prnewswire Kling Biotherapeutics , Michael Koslowski , Kling Biotherapeutics , Timothym Wright , Takeda Pharmaceuticals , University Of Mainz , Mission Therapeutics , University Of Cologne , Boehringer Ingelheim , University Of The Saarland , Glenmark Pharmaceuticals , Gammadelta Therapeutics , Chief Medical Officer , New Targets , Antibody Development , Ganymed Pharmaceuticals , Translational Oncology , Tv ,